179 related articles for article (PubMed ID: 8704625)
1. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients].
Dunaev VV; Kraĭdashenko OV; Berezin AE
Eksp Klin Farmakol; 1996; 59(1):21-3. PubMed ID: 8704625
[TBL] [Abstract][Full Text] [Related]
2. [The use of the antioxidant coenzyme Q10 as a cytoprotection variant in ischemic heart disease].
Syrkin AL; Kogan AKh; Drinitsina SV; Kuznetsov AB; Pechorina EA; Frenkel' EE; Kuleshova NN; Golovnia LD
Klin Med (Mosk); 1998; 76(7):24-8. PubMed ID: 9742773
[No Abstract] [Full Text] [Related]
3. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
Makolkin VI; Vakhliaev VD
Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
[TBL] [Abstract][Full Text] [Related]
4. [A mathematical analysis of the cardiac activity indices in patients with ischemic heart disease undergoing antianginal pharmacotherapy].
Arushanian EB; Shamliian TA
Eksp Klin Farmakol; 1995; 58(1):31-3. PubMed ID: 7787692
[TBL] [Abstract][Full Text] [Related]
5. [Cardiometabolic therapy of ischemic heart disease].
Vasil'ev AP; Strel'tsova NN; Senatorov IuN
Klin Med (Mosk); 2004; 82(4):59-62. PubMed ID: 15164513
[TBL] [Abstract][Full Text] [Related]
6. [The potentials of combined anti-arrhythmia therapy with the use of neuroactive amino acids in patients with ischemic heart disease].
Skibitskiĭ VV
Ter Arkh; 1992; 64(8):25-9. PubMed ID: 1279829
[No Abstract] [Full Text] [Related]
7. [A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
Belousov IuB; Upnitskiĭ AA; Sokolov AV; Tishchenkova NF; Karasev AV; Egorova NA
Ter Arkh; 1997; 69(3):61-3. PubMed ID: 9229836
[No Abstract] [Full Text] [Related]
8. [The effect of histochrome on the lipid peroxidation indices during the surgical treatment of patients with ischemic heart disease of different functional classes].
Afanas'ev SA; Lasukova TV; Cherniavskiĭ AM; Vecherskiĭ IuIu; Ponomarenko IV
Eksp Klin Farmakol; 1999; 62(6):32-4. PubMed ID: 10650524
[TBL] [Abstract][Full Text] [Related]
9. [The optimization of the hemodynamic characteristics in patients with ischemic heart disease and circulatory failure by using a substrate-coenzyme complex].
Vizir AD; Dunaev VV; Berezin AE; Kraĭdashenko OV
Lik Sprava; 1997; (5):53-6. PubMed ID: 9491697
[TBL] [Abstract][Full Text] [Related]
10. [The efficacy of propaphenol in extrasystole in patients with ischemic heart disease].
Dobrotvorskaia TE; Rybakova MK; Suprun EK; Arifullin ShS
Ter Arkh; 1992; 64(12):30-2. PubMed ID: 1284005
[No Abstract] [Full Text] [Related]
11. [An amino acid metabolic complex in optimizing the cardiac hemodynamic characteristics of patients with ischemic heart disease].
Berezin AE; Fushteĭ IM; Kraĭdashenko OV
Lik Sprava; 1998 Dec; (8):94-6. PubMed ID: 10204359
[TBL] [Abstract][Full Text] [Related]
12. [Indices of lipid peroxidation and atherogenic blood lipoproteins in patients with coronary heart disease receiving antioxidants in addition to basic therapy].
Reĭzin AB; Tel'nykh IuV
Klin Med (Mosk); 2005; 83(11):63-4. PubMed ID: 16404943
[TBL] [Abstract][Full Text] [Related]
13. [The correlations of lipid peroxidation, antioxidant protection and microrheological disorders in the development of IHD].
Zakirova AN
Ter Arkh; 1996; 68(9):37-40. PubMed ID: 9005610
[TBL] [Abstract][Full Text] [Related]
14. [Blood lipids, lipid peroxidation and the effect on them of antianginal preparations in ischemic heart disease patients].
Serkova VK; Zhebel' VN; Filenko LV; Savitskaia EA
Eksp Klin Farmakol; 1998; 61(2):75-8. PubMed ID: 9621182
[TBL] [Abstract][Full Text] [Related]
15. [The effect of helium-neon laser irradiation on myocardial and thyroid functions in patients with ischemic heart disease].
Ruzov VI; Rubanova MP; Grigor'ev MIu; Cherkunov KV
Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (5):7-9. PubMed ID: 9446315
[No Abstract] [Full Text] [Related]
16. [The efficacy of basic antianginal preparations in patients with stenocardia after the aortocoronary bypass operation].
Vykhovaniuk IV
Ter Arkh; 1991; 63(8):41-5. PubMed ID: 1792615
[TBL] [Abstract][Full Text] [Related]
17. [Effect of a compound preparation pumpan on exercise tolerance and clinical course of ischemic heart disease].
Krasnitskiĭ VB; Aronov DM; Zhidko NI
Ter Arkh; 2003; 75(8):17-21. PubMed ID: 14520844
[TBL] [Abstract][Full Text] [Related]
18. [Agents for the metabolic correction of myocardial energy metabolism in treating patients with ischemic heart disease].
Vizyr AD; Kraĭdashenko OV; Berezin OIe; Oliĭnyk OI
Lik Sprava; 2000 Mar; (2):26-30. PubMed ID: 10862469
[TBL] [Abstract][Full Text] [Related]
19. [The chronobiological aspects of drug resistance to antianginal therapy].
Arushanian EB; Shamliian TA
Eksp Klin Farmakol; 1994; 57(4):33-5. PubMed ID: 7950781
[TBL] [Abstract][Full Text] [Related]
20. ["Running" pulse magnetic field in treating stenocardia].
Orlov LL; Makoeva LD; Pochechueva GA; Arzhanenko OM; Belinskaia TF
Biofizika; 1996; 41(4):949-52. PubMed ID: 8962896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
